Meighan Seema, Lipman Terri H, VanGraafeiland Brigit, Marks Brynn E
Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Johns Hopkins School of Nursing, Baltimore, Maryland.
Sci Diabetes Self Manag Care. 2025 Feb;51(1):64-72. doi: 10.1177/26350106241306058. Epub 2025 Jan 9.
The purpose of the study was to identify the most common reasons for and timing of continuous glucose monitoring (CGM) attrition in youth with type 1 diabetes (T1DM).
This single center retrospective chart review included youth with T1DM <22 years seen between November 1, 2021, and October 31, 2022. Data were gathered from CGM cloud-based software and the electronic medical record.
Among 2663 youth, 88.3% (n = 2351) actively used CGM, and 5.9% (n = 311) had CGM attrition. Those who discontinued CGM were older (17.0 vs 14.9 years, = .0001), had a longer T1DM duration (7.4 vs 5.1 years), higher A1C (9% vs 7.4%), and were non-Hispanic Black (NHB; 34.0% vs 11.5%). The odds of CGM attrition were 5.0 and 2.8 times higher in NHB and Latine youth, respectively, compared to non-Hispanic White youth. Median time to CGM discontinuation was 4 months, 21 days after initiation; 57% of youth who discontinued did so in the first 6 months of use. The most common reasons for CGM attrition were problems with device adhesion (18.4%), dislike device on the body (10.8%), insurance problems (9.5%), pain with device use (8.3%), and system mistrust due to inaccurate readings (8.2%). NHB and Latine youth were more likely to discontinue CGM due to insurance problems (3.2% vs 15.1% vs 16.7%).
To support equitable, uninterrupted CGM use, education at CGM initiation should address practical approaches to improve adhesion and wearability and provide a clear pathway to obtaining supplies. Interventions to support sustained CGM use should occur within the first 6 months of initiation.
本研究旨在确定1型糖尿病(T1DM)青少年持续葡萄糖监测(CGM)停用的最常见原因及时间。
这项单中心回顾性病历审查纳入了2021年11月1日至2022年10月31日期间就诊的年龄小于22岁的T1DM青少年。数据从基于CGM的云软件和电子病历中收集。
在2663名青少年中,88.3%(n = 2351)积极使用CGM,5.9%(n = 311)出现CGM停用。停用CGM的青少年年龄较大(17.0岁对14.9岁,P = .0001),T1DM病程较长(7.4年对5.1年),糖化血红蛋白(A1C)较高(9%对7.4%),且为非西班牙裔黑人(NHB;34.0%对11.5%)。与非西班牙裔白人青少年相比,NHB和拉丁裔青少年停用CGM的几率分别高出5.0倍和2.8倍。停用CGM的中位时间为开始后4个月零21天;57%的停用青少年在使用的前6个月内停用。CGM停用的最常见原因是设备粘贴问题(18.4%)、不喜欢身上佩戴设备(10.8%)、保险问题(9.5%)、使用设备时疼痛(8.3%)以及因读数不准确导致对系统不信任(8.2%)。NHB和拉丁裔青少年因保险问题更有可能停用CGM(3.2%对15.1%对16.7%)。
为支持公平、不间断地使用CGM,在开始使用CGM时进行的教育应涉及改善粘贴和可穿戴性的实用方法,并提供获取耗材的明确途径。支持持续使用CGM的干预措施应在开始使用的前6个月内进行。